Consider building positions in Bitcoin (BTC) as it attempts a breakout past the $70,000 resistance level on favorable U.S. regulatory momentum.

Maintain long exposure to NVIDIA (NVDA) ahead of its upcoming earnings report, as diversified compute demand from leading AI developers continues to drive triple-digit revenue growth.

Buy the dip on Broadcom (AVGO) following its recent pullback, as market fears over custom chip competition from Marvell Technology (MRVL) are overblown and core tech partnerships remain intact.

Generate income or establish a discounted entry in Meta Platforms (META) by selling December $500 strike puts, leveraging its highly profitable advertising business and low valuation relative to private AI firms.

Exercise caution and avoid chasing Moderna (MRNA) after its triple-digit surge, waiting instead for clear commercial timelines and valuation clarity on its cancer vaccine.

Bitcoin (BTC)

• Bitcoin traded near $69,000, attempting to break out toward the $70,000 psychological level.
• The rally was driven by regulatory optimism, including discussions around the Clarity Act, digital asset security legislation, and high-profile meetings between Donald Trump and crypto executives like Brian Armstrong and Vlad Tenev.
• Broader fintech and crypto-related equities rallied alongside the token.

Takeaways

• Favorable U.S. regulatory momentum and potential legislative progress (such as the Clarity Act) serve as immediate positive catalysts for BTC and the broader cryptocurrency market.

Hyperliquid (HYPE) / Purr (PURR)

• The Commodity Futures Trading Commission (CFTC) is reportedly working toward establishing a compliant pathway to bring Hyperliquid (a decentralized perpetual futures exchange) into the United States.
• The platform enables perpetual futures contracts with leverage ranging from 10x to 30x on equities and crypto assets.
• Related assets rallied significantly on the news, with HYPG rising 18% and PURR (seen as a treasury proxy asset held by institutional investors like Stanley Druckenmiller) gaining 30%.

Takeaways

• Enabling legal perpetual futures trading in the U.S. could unlock significant on-chain trading volumes, benefiting decentralized exchange ecosystems and tokenization plays.

Moderna (MRNA)

• Moderna surged between 170% and 177% in a single session following successful clinical trial results for its personalized mRNA cancer vaccine for melanoma.
• The company's market capitalization expanded by $44 billion, moving from $25 billion to approximately $69 billion.
• Commentators noted that while mRNA technology holds transformative long-term potential for disease treatment, assigning an immediate fundamental valuation after such an explosive move carries elevated risk.

Takeaways

• While the trial success represents a massive milestone for mRNA oncology pipelines, investors should exercise caution chasing the stock after a triple-digit one-day surge until commercial timelines and market size are clarified.

Webull (BULL)

• Webull reported strong Q2 financial results, beating analyst expectations on both the top and bottom lines.
• Revenue rose 51% year-over-year to $200 million (vs. $180 million expected), and EPS came in at $0.04 (vs. $0.02 expected).
• Trading volumes surged, supported by active trader features following changes to day-trading rules, sending the stock up approximately 7% to 8% in post-market trading.

Takeaways

• Webull is demonstrating operating leverage and accelerating top-line growth driven by higher retail trading engagement and crypto momentum.

NVIDIA (NVDA)

• NVIDIA briefly touched $223 ahead of its upcoming quarterly earnings report, where analysts expect triple-digit revenue growth to roughly $94 billion to $95 billion with gross margins remaining above 75%.
• Recent market concerns regarding slower sequential revenue growth at OpenAI were dismissed as unproblematic for NVDA, because high-end AI compute capacity remains fungible across different labs (such as Anthropic and xAI).
• NVIDIA is expanding its competitive moat through financing infrastructure partnerships and exclusive chip supply deals, including a partnership with SpaceX.

Takeaways

• NVDA remains the primary infrastructure beneficiary of the ongoing AI buildout, with robust demand across competing model builders insulating it from single-client volatility.

Nebius Group (NBIS)

• Nebius declined roughly 10% to 12% following the announcement of a convertible note offering.
• The panel viewed the capital raise as a standard and necessary step for emerging "Neocloud" providers to secure data center land, power, and GPUs to scale revenue capacity.

Takeaways

• Short-term share dilution is creating price volatility, but funding capacity expansions is an essential prerequisite for Neocloud providers to capture long-term AI compute demand.

Marvell Technology (MRVL) & Broadcom (AVGO)

• Marvell gained 9% following news of Google’s strategic interest and component integration at a $207 price reference.
• Broadcom fell roughly 4% on fears of lost custom silicon (TPU) market share to Marvell.
• The hosts argued the market overreacted: Google is diversifying surrounding components (memory controllers and accelerators) rather than replacing Broadcom's core ASIC design role.

Takeaways

• The custom silicon (ASIC) ecosystem is expanding rather than operating as a zero-sum game; MRVL benefits from broader design wins while AVGO's core TPU partnership remains fundamentally intact.

Meta Platforms (META)

• Meta shares traded relatively flat to slightly lower, impacted by broad advertising sentiment and ongoing regulatory lawsuits concerning app mechanics.
• The hosts highlighted that Meta generates $200 billion in highly profitable revenue, trades at a compelling valuation compared to private AI labs, and is successfully monetizing AI through targeted advertising algorithms.
• Options traders on the panel highlighted selling the $500 strike put for December as an attractive risk-reward play.

Takeaways

• Meta remains one of the most cost-effective ways to play applied AI monetization in mega-cap tech, with strong core advertising fundamentals offsetting headline regulatory noise.

Reddit (RDDT)

• Reddit pulled back to pre-earnings levels due to concerns that search referral traffic is declining, alongside data showing Reddit's share of ChatGPT search citations fell from 3.8% to 0.5%.
• The core bullish thesis relies on Reddit leveraging its unique, human-generated discussion data to negotiate lucrative multi-million-dollar training and licensing contracts with major AI model developers.

Takeaways

• Watch for upcoming data licensing agreements with AI labs as the primary catalyst to offset potential volatility in organic search referral traffic.